Effective Immediately: OncoSec Names Former Advaxis Exec as New CEO Post author:Sam Post published:November 7, 2017 Post category:BioPharma OncoSec Medical today announced the appointment of Daniel J. O’Connor as CEO of the Company. Source: BioSpace You Might Also Like RedHill Biopharma To Host Second Quarter 2017 Financial Results Conference Call On July 25, 2017 July 17, 2017 Phenomenex Announces Direct Sales And Support In Switzerland September 5, 2017 Medtronic Announces Japanese Regulatory Approval For Micra Transcatheter Pacing System (TPS) February 16, 2017
RedHill Biopharma To Host Second Quarter 2017 Financial Results Conference Call On July 25, 2017 July 17, 2017
Medtronic Announces Japanese Regulatory Approval For Micra Transcatheter Pacing System (TPS) February 16, 2017